IgG4 and IgG1 undergo common acid‐induced compaction into an alternatively folded state

Imamura H, Honda S, FEBS Letters (2025) DOI

SASDW54 – Immunoglobulin G1 (pH 2, 0.2 M NaCl), SEC-SAXS data

humanized immunoglobulin G1 monoclonal antibody (trastuzumab)
MWI(0) 131 kDa
MWexpected 148 kDa
VPorod 240 nm3
log I(s) 9.56×10-2 9.56×10-3 9.56×10-4 9.56×10-5
humanized immunoglobulin G1 monoclonal antibody (trastuzumab) small angle scattering data  s, nm-1
ln I(s)
humanized immunoglobulin G1 monoclonal antibody (trastuzumab) Guinier plot ln 9.56×10-2 Rg: 4.2 nm 0 (4.2 nm)-2 s2
(sRg)2I(s)/I(0)
humanized immunoglobulin G1 monoclonal antibody (trastuzumab) Kratky plot 1.104 0 3 sRg
p(r)
humanized immunoglobulin G1 monoclonal antibody (trastuzumab) pair distance distribution function Rg: 4.2 nm 0 Dmax: 12.9 nm

Data validation


There are no models related to this curve.

Synchrotron SAXS data from solutions of Immunoglobulin G in 100 mM glycine-HCl, 200 mM NaCl, pH 2 were collected on the BL-10C beam line at the Photon Factory High Energy Accelerator Research Organization (KEK; Tsukuba, Japan) using a Pilatus3 2M detector at a sample-detector distance of 2 m and at a wavelength of λ = 0.15 nm (I(s) vs s, where s = 4πsinθ/λ, and 2θ is the scattering angle). In-line size-exclusion chromatography (SEC) SAS was employed. The SEC parameters were as follows: A 400.00 μl sample at 10 mg/ml was injected at a 0.20 ml/min flow rate onto a GE Superdex 200 Increase 10/300 column at 25°C. 13 successive 20 second frames were collected. The data were normalized to the intensity of the transmitted beam and radially averaged; the scattering of the solvent-blank was subtracted.

DrugBank ID: DB00072 https://go.drugbank.com/drugs/DB00072. Heavy chains' C-terminal K residues are deleted for Herceptin (Chugai Pharmaceutical Co., Ltd., Tokyo, Japan), commercially available trastuzumab, according to the information in PMDA (Pharmaceuticals and Medical Devices Agency): Review report regarding the anti-HER2 humanized monoclonal antibody Herceptin® Injection 60 and 150, on Jan. 16th 2008 (https://www.pmda.go.jp/drugs/2007/P200700066/45004500_21300AMY00128_A100_2.pdf).

humanized immunoglobulin G1 monoclonal antibody (trastuzumab) (IgG1)
Mol. type   Protein
Organism   Mouse/human
Olig. state   Monomer
Mon. MW   148 kDa
Sequence   FASTA